Canada markets closed

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
5.73+0.04 (+0.70%)
At close: 04:00PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 579.71M
Enterprise Value 478.63M
Trailing P/E N/A
Forward P/E 95.24
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.88
Price/Book (mrq)0.78
Enterprise Value/Revenue 1.46
Enterprise Value/EBITDA 11.70

Trading Information

Stock Price History

Beta (5Y Monthly) 0.49
52-Week Change 324.30%
S&P500 52-Week Change 322.36%
52 Week High 35.95
52 Week Low 34.35
50-Day Moving Average 35.50
200-Day Moving Average 35.09

Share Statistics

Avg Vol (3 month) 373.48k
Avg Vol (10 day) 347.12k
Shares Outstanding 5101.17M
Implied Shares Outstanding 6101.17M
Float 852.06M
% Held by Insiders 146.44%
% Held by Institutions 113.67%
Shares Short (Apr 15, 2024) 43.21M
Short Ratio (Apr 15, 2024) 434.66
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 43.15%
Shares Short (prior month Mar 15, 2024) 43.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -5.13%
Operating Margin (ttm)-0.11%

Management Effectiveness

Return on Assets (ttm)0.40%
Return on Equity (ttm)-2.14%

Income Statement

Revenue (ttm)328.2M
Revenue Per Share (ttm)3.05
Quarterly Revenue Growth (yoy)-9.10%
Gross Profit (ttm)N/A
EBITDA 53.26M
Net Income Avi to Common (ttm)-16.84M
Diluted EPS (ttm)-0.16
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)169.87M
Total Cash Per Share (mrq)1.68
Total Debt (mrq)69.09M
Total Debt/Equity (mrq)9.25%
Current Ratio (mrq)3.20
Book Value Per Share (mrq)7.38

Cash Flow Statement

Operating Cash Flow (ttm)35.94M
Levered Free Cash Flow (ttm)27.2M